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Abstract 
Naphthalene diimide carrying four ferrocenyl substituents, tFND1 and tFND2, were newly 
synthesized to expect the improved binding affinity for tetraplex DNA and specific electrochemical 
signal generation. tFND2 shows the 1:2 binding to tetraplex A-core DNA, which has a part of human 
telomere sequence based on circular dichroism spectra, and the current increase of tFND2 on the 
tetraplex DNA-immobilized electrode was 13.5-times higher than that on the single stranded 
DNA-immobilized electrode. When applied to an electrochemical telomerase assay (ECTA) for 
HeLa cell, tFND2 shows the quantitative change around 0.1-50 cells/μL and the detection limit of 
0.1 cells/μL for HeLa cell. 
Keywords: electrochemical detection, telomerase activity, tetraplex DNA specific ligand, 
tetra-substituted naphthalene diimide, ferrocene 
1. Introduction
Oral cancer is known to show a mild pain or uncomfortable feeling in an early phase and to be found 
out in a progress stage. Treatment under the progress stage causes a bottleneck in eating, talking, and 
breathing, resulting in a decline in the quality of life. Under such circumstances, it is important to 
develop the oral cancer diagnosis method under the early stage and especially a simple and rapid 
diagnostic method desired because of the absence of distinctive symptom under the early stage. 
Many researchers have been focusing on a telomerase activity, which is known to act in over 80 % 
cancer cell even in the early stage [1]. 
Conventional telomerase detection has hitherto been carried out with the telomerase repeating 
amplification protocol (TRAP), which is based on the observation of band length of the telomere 
DNA fragments elongated from a telomerase substrate (TS)-primer with telomerase under gel 
electrophoresis [2]. This TRAP requires a PCR and the gel electrophoresis, which contains a tedious 
and time-consuming procedures. Our developing method is based on an electrochemical method 
using TS-primer-immobilized electrode and electrochemically active tetraplex DNA ligand. Other 
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groups also developed the electrochemical telomerase assay [3-7]. Shao et al. achieved from the 
oxidation current of guanine (G) of the elongated telomere DNA on the electrode [3]. They utilized 
the ITO electrode because of its large potential window to detect 1.0 V of the oxidation voltage of G. 
The detection limit of this method was 50 ng/μL of telomerase [3]. Lin et al. also developed 
telomerase detection using the methylene blue-modified hairpin DNA probe carrying a 
complementary sequence of telomere DNA (MB-HP DNA), TS-primer, and T7 exonuclease [4]. 
Telomerase elongated TS-primer and hybridized with many MB-HP DNAs, which are correlated the 
length of the elongated TS-primer to digest with T7 exonuclease resulting in many mononucleotides 
having methylene blue. These mononucleotides showed a reduction on the ITO electrode. 
Telomerase activity from a single cancer cell was detected using this technique [4]. 
  Before these papers, we have been developing the electrochemical telomerase assay (ECTA) and 
successfully achieved the oral cancer diagnosis using cells collected with the brushing of inside the 
mouth [5-7]. Principle and procedure of this method were shown in Fig.1. As an initial stage, we 
utilized ferrocenyl naphthalenediimide (FND)7 as an electrochemical tetraplex DNA ligand. Other 
metallocenes such as manganocene and cobaltocene are also electrochemically stable and might be 
useful as an electrochemically labeling probe for biological assay [8]. We chose ferrocene in our 
system. Ferrocene has the redox potential at the positive side, which is not overlapped redox 
potential dissolved oxygen in an aqueous medium at the negative side. However, the redox potential 
of FND7 was a 0.45 V vs. Ag/AgCl, which region affected non-Faraday current and showed the 
detection limit of 50 HeLa cells [5]. When the use of FND3 instead of FND7, detection limit was 
improved to 10 cells [7] 
According to the importance of tetraplex DNA ligand in cancer therapy, tri- or tetra-substituted 
naphthalene diimide have been drawing attention and tetra-substituted naphthalene diimide is known 
to show an improved binding affinity for tetraplex DNA [9]. Here, we designed and synthesized 
naphthalene diimide derivatives carrying four ferrocenyl substituents, tFND1 and tFND2 to improve 





FND3 and FND7 were synthesized according to the procedure previously reported [10]. The custom 
synthesized oligonucleotide was purchased from Genenet (Fukuoka, Japan). Oligonucleotides used 
in this experiment are shown in Table 1. 
 
2.2 Synthesis of tFND1 
tFND1 was synthesized as shown in Scheme 1. Brominated naphthalene tetra-anhydride ND-Br2 in 
100 mL toluene was synthesized according to a previous report [11]. The mixture of 1.0 g (2.3 
mmol) of ND-Br2 and 4.2 ml (4.0 mmol) of N-methyl-1,3-diaminopropane in a flask was irradiated 
with microwave (150°C, 700 W) for 2 min. After cooling, toluene was removed under reduced 
pressure to obtain the blackish green viscous oil. The obtained residuals dried at 130°C under 4 kPa 
and filtrated upon addition of methanol. The obtained filtrate was purified by the medium pressure 
preparative liquid chromatography (YAMAZEN Parallel Frac FR-360, UV-DETECTOR prep 
UV-254, PUMP 58) under gradient conditions, where the acetonitrile content in 0.1% trifluoroacetic 
acid was changed linearly from 8 to 40% over 38 min at a flow rate of 30 mL/min with detection at 
254 nm. The elute of Rf=0.13 (CHCl3 : CH3OH : diethylamine = 10 : 1 : 0.8) was collected and 
obtained 0.20 g (0.35 mmol) of TND1. The mixture of 0.12 g (0.21 mmol) of TND and 0.47 g (1.2 
mmol) of (ferrocenylmethyl)trimethyl–ammonium iodide in 6.2 mL of DMF was heated in a shaded 
flask at 60°C for 62 hr. After cooling and removing DMF under reduced pressure, the blue colored 
solid was obtained. After added 50 mL of chloroform, it was washed with 50 mL of aqueous solution 
seven times. The solution was evaporated and the residue was subjected to silica gel chromatography. 
tFND1 was obtained as 44 mg (0.03 mmol) of blue colored solid after purified by silica gel 
chromatography using the mixture of CHCl3 : CH3OH : diethylamine = 10:1:0.2 as an eluent. Pure 
tFND1 identified by reversed HPLC (Fig. S1) was assigned by MALDI-TOF -MS (Fig. S2) and 
1H-NMR (Fig. S3). 1H-NMR (400 MHz, CDCl3) 1.89 (m, 8H), 2.19 (s, 6H), 2.20 (s, 6H), 3.43 (s, 
8H), 3.50 (q, 4H), 4.04-4.18 (m, 40H), 8.16 (s, 2H), 9.35 (t, 2H) ppm; MALDI-TOF-MS m/z 
[M+H]+ 1376.6 (Calcd. for C74H84Fe4N8O4+H+ 1373.89). 
 
2.3. Synthesis of tFND2 
tFND2 was synthesized as shown in Scheme 2. The mixture of 0.34 g (0.80 mmol) of ND-Br2 and 
1.5 g (4.8 mmol) of p-NH2 (Boc) [10] in a flask was refluxed for 71 hr. After cooling, toluene was 
removed under reduced pressure, and 1 L of Milli-Q water was added and carried out ultrasonic 
irradiation. After filtration and removed to water under reduced pressure, 0.84 g (0.59 mmol) of 
purple-colored viscous solid was obtained. This solid mainly containing tNDI-p-Boc was added in 
10 mL of trifluoroacetic acid and stirred for 90 min at room temperature. Solvent was removed under 
reduced pressure and 0.45 g (0.19 mmol) of tNDI-p-NH2 was purified as blue-colored content at 13 
min by the medium pressure preparative liquid chromatography under gradient conditions, where the 
acetonitrile content in 0.1% trifluoroacetic acid was changed linearly from 5.6 to 70% over 40 min at 
a flow rate of 20 mL/min with detection at 254 nm. 
  Five mL of DMF containing 0.30 g (0.13 mmol) of tNDI-p-NH2 and 5 mL of trimethylamine was 
added with the mixture of 20 g (0.76 mmol) of ferrocenylpropanoic acid [10] in 5 mL of DMF and 5 
mL of trimethylamine and consequently added with 2.4 g (4.5 mmol) of 
1H-Benzotriazol-1-yloxy-tri(pyrrolidino)phosphonium hexafluorophosphate (PyBOP, Watanabe 
Chemical Industries LTD, Hiroshima, Japan) and 0.61 g (4.53 mmol) of 
1-Hydroxy-1H-benzotriazole hydrate (Watanabe Chemical Industries LTD) and stirred for 27 hr at 
room temperature in shaded flask. After removed the solvent and added 80 mL of chloroform and 
filtrated. The filtrate was washed with 30 mL of saturated sodium bicarbonate aqueous solution three 
times, and this filtrate was dried over anhydride Na2SO4. After added with diethyl ether and carried 
out ultrasonic irradiation. After filtration, precipitates were subjected to silica gel chromatography 
using the mixture of CHCl3 : diethylamine = 10 : 0.75 as an eluent. tFND2 was obtained as 0.20 g 
(0.10 mmol) of blue colored solid after purified by Pure tFND2 identified by reversed HPLC (Fig. 
S4) was assigned by MALDI-TOF-MS (Fig. S5), 1H-NMR (Fig. S6), 13C-NMR (Fig. S7) and 
Elemental analysis. 1H-NMR (400 MHz, CDCl3) 1.66 (m, 8H), 1.80 (m, 8H), 1.92 (m, 8H), 
2.30-2.52 (m, 48H), 3.14 (m, 8H), 3.29 (m, 8H), 3.56 (q, 4H), 4.01-4.10 (m, 36H), 4.22 (t, 4H), 8.15 
(s, 2H), 9.39 (t, 2H) ppm; 13C-NMR (500 MHz, CDCl3) 172.2, 166.2, 163.1, 149.2, 125.8, 121.2, 
118.4, 102.0, 87.7, 77.3, 77.0, 76.7, 68.6, 68.0, 67.3, 57.6, 56.0, 55.7, 53.5, 53.3, 53.2, 53.1, 41.3, 
39.6, 38.9, 38.8, 31.9, 29.7, 26.7, 26.0, 25.2, 25.0, 24.9, 22.7 ppm; MALDI-TOF-MS m/z [M+H]+ 
1991.9 (Calcd. for C106H140Fe4N16O8+H+ 1990.7). Elemental analysis: (%) calcd for 
C106H140Fe4N16O8·H2O : C 63.99, H 7.09, N 11.26; Found: C 63.40, H 7.13, N 11.16. 
 
2.4 CD spectra measurements 
CD spectra of 1.5 μM a-core (Table 1) was corrected in the absence or presence of varied amounts of 
tFND1 or tFND2 up to 6.0 μM or 9.0 μM ([tFND]/[A-core] = 4 or 6) in 100 mM AcOH-AcOK 
buffer (pH 5.5) and 100 mM KCl using JASCO J-820 spectrometer (Jasco Inc., Tokyo, Japan). 
 
2.5 Electrochemical measurements 
2.5.1 Preparation of sensing electrode 
For 6-mercaptoethanol immobilized electrode, printed gold electrode (ϕ 1.6 mm, Tanaka Kikinzoku 
Kogyo, Tokyo, Japan) was irradiation of O2 plasma at 0.5 Torr for 30 s (Cute-MP, Femto 
Science, Gyeonggi, South Korea) and dipped into 4 μL of 1.0 mM 6-mercaptohexanol and kept 
for 1 hr at 45°C. After washed with Milli-Q water and blow off by nitrogen gas. For HS-Single and 
HS-G4 (Table 1) immobilized electrode, printed gold electrode (ϕ 1.6 mm, Tanaka Kikinzoku 
Kogyo) was irradiation of O2 plasma at 0.5 Torr for 30 s and dipped into 10 μL probe DNA in 100 
mM NaCl and kept for 2 hr at 37°C and was subsequently dipped 4 μL of 1 mM 6-mercaptohexanol 
and kept for 1 hr at 45°C. After washed with Milli-Q water and blow off by nitrogen gas.  
 
2.5.2 Electrochemical measurements 
CV measurements was using with three configuration of reference electrode of Ag/AgCl, Pt counter 
electrode, and printed gold electrode as working electrode using Electrochemical Analyzer 
Model 650C (CH Instrument, Austin, TX) with the electrolyte of 100 mM AcOH-AcOK buffer 
(pH 5.5) and 100 mM KCl containing 50 μM tFND1 or 100 mM AcOH-AcOK buffer (pH 5.5), 100 
mM KCl, and 40%DMSO containing 20 μM tFND2. Chronocoulometry (CC) was carried out 
according to the method previously reported [13]. SWV was measured in 100 mM AcOH-AcOK 
buffer (pH 5.5), 100 mM KCl, and 5 μM tFND1 or 100 mM AcOH-AcOK buffer (pH 5.5), 100 mM 
KCl, and 40% DMSO containing 5 μM tFND2. 
 
2.5.3 Electrochemical telomerase assay (ECTA) 
HS-T8TS1 (Table 1) was immobilized on the printed electrode (Fig. S8A), and the elongation 
reaction on this electrode was carried out according to the procedure previously described [7]. The 
electrode was washed with dipping into 10 mL of MilliQ water and RNase free water (0.2 U/μL 
RNase inhibitor) before the telomerase reaction. The telomerase reaction was then run in 10 μL of 50 
mM Tris-HCl (pH 8.0) containing 0.01-50 cells/μL HeLa cell lysate, 1.0 mM MgCl2, 50 mM KCl, 
0.10 mM 2-mercaptoethanol, 0.10 mM spermidine, 10 μM dNTP mixture at 37 °C for 30 min. 
The electrode was washed with dipping into 10 mL of MilliQ water, 1×PBS, and 100 mM 
AcOH-AcOK buffer (pH 5.5) containing 100 mM KCl before SWV measurement (Fig. 7B). Before 
and after the telomerase reaction, SWV measurements were carried out in 100 mM AcOH-AcOK 
buffer (pH 5.5), 100 mM KCl, and 40 % DMSO containing 20 μM tFND2. Telomerase activity was 
evaluated using the following the equation; Δi = (i-i0)/i0×100, where i and i0 are referred to current 
before and after telomerase reaction, respectively. 
 
3. Results and discussion 
 
3.1 Electrochemical behavior of tFDN1 and tFND 
Figure 2 shows cyclic voltammogram of 50 μM tFND1 was measured in a 
6-mercaptoethanol-immobilized electrode in 100 mM AcOK-AcOH buffer (pH 5.5) and100 mM 
KCl to obtain the following parameters: 432 mV of redox potential (E1/2) from 453 mV of oxidation 
potential (Epa), 411 mV of reduction potential. From low servility of tFND2 in an aqueous medium, 
tFND2 was dissolved in DMSO as stocked solution and the cyclic voltammogram of 20 μM tFND2 
was measured in the 6-mercaptoethanol-immobilized electrode under 100 mM AcOK-AcOH buffer 
(pH 5.5), 100 mM KCl, and 40% DMSO to obtain the following parameters: 261 mV of the redox 
potential (E1/2) from 292 mV of the oxidation potential (Epa), 230 mV of the reduction potential. 
Since FND3 carrying same ferrocenyl substituents has a 190 mV of E1/2 [11], tFND2 is positively 
shifted to 70 mV and this might come from the effect of the liquid junction potential in an aqueous 
electrolyte containing DMSO[14]. 
 Even after the consideration of this factor, the redox potential of tFND2 shows more negatively 
than that of tFND1. Scan rate dependence of the peak current of tFND1 and tFND2 in CV were 
measured and these currents were correlated with v1/2, which is suggesting their electron transfer 
from the electrode was diffusion process. 
 
3.2 Interaction of tFND1 and tFND2 with tetraplex DNA 
A-core is a part of the human telomere DNA sequence and is known to have a mixture of 
anti-parallel and hybrid tetraplex structures [15]. CD spectra of A-core upon addition of tFND1 and 
tFND2 in 100 mM AcOH-AcOK buffer (pH 5.5) and 100 mM KCl. Figure 3 (A) shows the positive 
Cotton effect at 290 nm and the negative one at 240 nm with the positive shoulder around 270 nm. 
Since this shoulder signed of the hybrid structure was increased with an increasing the amount of 
tFND1, tFND1 seems to induce the hybrid structure upon the binding to A-core. 
On the other hand, the intensity of the CD bands increased upon the addition of tFND2 up to twice 
of A-core concentration, suggesting binding of tFND2 with tetraplex DNA both tetraplex structure 
(Fig. 3B). Job’s plots were conducted using the CD intensity change at 290 nm, and the binding ratio 
of tFND1 and tFND2 to A-core was one and two as shown in Fig. 3C and D. 
 
3.3 Estimation of selectivity between tetraplex DNA and single stranded DNA on the electrode 
Under the ECTA, the electrochemical ligand is required the higher current signal for tetraplex DNA 
over single stranded one resulting in higher current signal. Current ratio (G4/Single) for tetraplex 
DNA to single stranded DNA on the electrode was evaluated from the current measurements of 
several FND derivatives in the tetraplex DNA or mercaptoethanol DNA immobilized electrode. 
Firstly, the amount of the tetraplex (HS-G4, 24 mer) or the single stranded DNA (HS-Single, 
24-mer) immobilized on the electrode was estimated by CC method with the procedure previously 
described[12]. Both DNAs was immobilized with 4.6×1011 molecules/cm2 and 8.6×1012 
molecules/cm2, respectively. Peak currents of these electrodes in tFND2 were 5.9×10-8 A and 
8.3×10-8 A, respectively and the division of peak current by the DNA-immobilized density gave the 
concentration amount of tFND2 normalized by DNA strand immobilized on the individual electrode. 
Current ratio (G4/Single) was calculated by the division of this normalized value in the case of 
tetraplex DNA by that in the case of single stranded DNA. According to this calculation, the current 
ratio (G4/Single) was 1.1, 1.6 and 1.8 for FND7 FND3, and tFND1, respectively, whereas Current 
ratio (G4/Single) for tFND2 was 13.5 suggesting the tFND2 has the highest preference for tetraplex 
DNA over single stranded one and has potentiality to improve ECTA performance (Fig. 4). tFND2 
has piperazine part in the linker. It is reported that 4-substituted naphthalenediimide strongly 
interacts with the phosphate of quadruplex DNA by introduced piperazine moieties into the linker 
portion [16]. The electrochemical measurement result was in agreement with the previous reports 
[16, 17]. 
 
3.4 Detection of telomerase activity in ECTA using tFND2 
Telomerase activity was estimated by ECTA using tFND1 or tFND2. In the case of tFND1 (Fig. S9), 
Δi was 45±20% after treatment of 0.1 cells/μL HeLa cell. However, too small i0 values and standard 
deviation, in this case, was too large to quantify the telomerase activity. On the other hand, in the 
case of tFND2, the i0 value of 0.28 μA increased to the i value of 0.76 μA after treated with 50 
cells/μL HeLa cells (Fig. 7A). Concentration dependence of Δi value in HeLa cell is shown in Fig. 
7B and shows the detection limit of 0.1 cells/μL using the 3σ method. The current increase was 
diminished about 80% compared with the case of 50 cells/μL HeLa cell treatment for heating 




Newly synthesized tFND1 and tFND2 bound to tetraplex DNA with 1:1 or 1:2 binding ratio, 
respectively. Preference of tFND2 between tetraplex DNA and single stranded one was higher than 
that of tFND1, and the stable current signal was observed in the ECTA system using tFND2 with 
quantitative change around 0.1-50 cells/μL and detection limit of 0.1 cells/μL. 
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Table 1. DNA used in this experiments  
Abbreviation DNA sequence 
A-core 5’-AGG GTT AGG GTT AGG GTT AGGG-3’ 
HS-Single HO-(CH2)6-S-S-(CH2)6-5'-TAG TTG TGT TTA TGT GTT TTT GTT-3’ 
HS-G4 
HO-(CH2)6-S-S-(CH2)6-5'-TTA GGG TTA GGG TTA GGG TTA G 
GG-3' 
HS-T8TS1 
HO-(CH2)6-S-S-(CH2)6-5'-TTT TTT TTT TAA TCC GTC GAG CAG 





Fig. 1. (A) Principle and procedure of an electrochemical telomerase assay (ECTA) and (B) Two 
designed naphthalene diimides carrying four ferrocenyl substituents, tFND1 and tFND2, derived 


























Fig. 2. Cyclic voltammogram of tFND1 (A) and tFND2 (B). Measurement was carried out using 
6-mercapthexanol-immobilized electrode in 50 μM tFND1, 100 mM AcOH-AcOK buffer (pH 
5.5), and 100 mM KCl (A) or 20 μM tFND2, 100 mM AcOH-AcOK buffer (pH 5.5), 100 


















Fig. 3. CD spectra of 1.5 μM a-core upon addition of tFND1 (A) and tFND2 (B) in 
100 mM AcOH-AcOK buffer (pH5.5) and 100 mM KCl. Job’s plots in the case of 
tFND1 (C) and tFND2 (D). CD change at 290 nm of A-core was plotted against molar 




Fig. 5. (A) SWV measurement before (dotted line) and after (solid line) treatment of 500 HeLa 
cells (50 cells/μL) in 100 mM AcOH-AcOK buffer (pH 5.5), 100 mM KCl, and 40% DMSO 
containing 20 μM tFND2. (B) Correlation of the current increase Δi with HeLa cell numbers. 
 
 
Fig. 4. Current ratio (G4/Single) of these ligands for tetraplex DNA over single 
stranded one. 
